Milberg LLP Announces Pendency of Class Action Lawsuit Against LHC Group (LHCG)

Free LHC Group Claim Evaluation

First Name*
Last Name*
Suffix:
Phone
Email*
State of Residence*
Tell us about your claim - If you reside outside of USA, note country here (Max 5000 Characters):
Select YES if you agree.*
The submission of information to Milberg LLP or one of its attorneys does not create, and the receipt of it does not constitute, an attorney-client relationship. This website presents general information about, among other things, Milberg LLP, currently pending lawsuits, and on-going investigations, which is not intended to be legal advice, nor should you consider it as such. Please do not send confidential or sensitive information and/or documents to anyone at the Firm until you have been notified that a formal attorney-client relationship has been established. Contacting Milberg LLP does not, and should not, limit you in any way from seeking legal advice regarding this or any other matter. By submitting this form, you agree that Milberg LLP may contact you about this or other potential matters of interest to investors and consumers.

NEW YORK — (BUSINESS WIRE) — Milberg LLP announces that a class action lawsuit was filed in the United States District Court for the Western District of Louisiana on behalf of purchasers of LHC Group, Inc. (NASDAQ:LHCG) common stock between July 30, 2008 and October 26, 2011, (the “Class Period”).

Milberg LLP has created a website that seeks to answer questions about shareholder class actions.

The complaint alleges that LHCG maximized revenue by manipulating the number of patient visits, regardless of patient need, and in effect over-billing Medicare.

On October 3, 2011, the Senate Finance Committee concluded that LHCG engaged in a practice that “at best represent[s] abuses of the Medicare home program” and “[a]t worst, they may be examples of for-profit companies defrauding the Medicare home health program at the expense of taxpayers.” On October 26, 2011, LHCG lowered its earnings forecast, in part to settle a government inquiry into whether LHCG improperly billed for home health services. LHCG ‘s stock price fell 15% in reaction to the news.

If you purchased LHCG shares during the Class Period you may, no later than August 13, 2012, request that the Court appoint you lead plaintiff of the proposed class. A lead plaintiff is a class member that represents other class members in directing the litigation. Your share in any recovery will not be affected by serving as a lead plaintiff, however, lead plaintiffs make important decisions that could affect the overall recovery for class members. You do not need to be a lead plaintiff to recover. You may retain Milberg LLP, or other attorneys, for this action, but do not need to retain counsel to recover. If this action is certified as a class action, class members will be automatically represented by Court-appointed counsel. The complaint in this action was not filed by Milberg.

If you would like to learn more about this potential matter, please fill out the form on the right or contact the following attorney:

Andrei Rado, Esq.
Milberg LLP
One Pennsylvania Plaza, 49th Fl.
New York, NY 10119-0165
Phone number: (800) 320-5081
Email: contactus@milberg.com

Milberg LLP has been representing consumers and investors for more than four decades and serves as lead counsel in federal and state courts throughout the United States.

Attorney Advertising.
Prior Results Do Not Guarantee A Similar Outcome.